Evidence map›Paper›PMID 25536276›Full record

ArticleAmerican journal of respiratory and critical care medicine2015

Lymphocytic alveolitis is associated with the accumulation of functionally impaired HIV-specific T cells in the lung of antiretroviral therapy-naive subjects.

C Preston Neff, Jennifer L Chain, Samantha MaWhinney, Allison K Martin, Derek J Linderman, Sonia C Flores, Thomas B Campbell, Brent E Palmer, Andrew P Fontenot

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. HIV-associated lung disease.Nature reviews. Disease primers · 2023
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Smoking and Human Immunodeficiency Virus 1 Infection Promote Retention of CD8American journal of respiratory cell and molecular biology · 2021
    Article
  14. Article
  15. Review
  16. Article
  17. Chronic obstructive pulmonary disease in HIV.Expert review of respiratory medicine · 2021
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

C Preston Neff1 Department of Medicine.
Jennifer L Chain
Samantha MaWhinney
Allison K Martin
Derek J Linderman
Sonia C Flores
Thomas B Campbell
Brent E Palmer
Andrew P Fontenot
Institute for Medical Informatics and Biostatistics · CHUniversity of Colorado Anschutz Medical Campus · US

Funding

Colorado Clinical and Translational Sciences InstituteUL1TR001082 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2013 to 2017
$48.0M
Colorado Clinical and Translational Science Institute (UL1)UL1TR000154 · NCATS · UNIVERSITY OF COLORADO DENVER · PI SOKOL, RONALD J. · 2012 to 2013
$20.4M
TRAINING PROGRAM IN IMMUNOLOGYT32AI007405 · NIAID · UNIVERSITY OF COLORADO DENVER · PI Laurel L Lenz, Raul Martin Torres · 1991 to 2026
$10.5M
Alterations in Lung Microbiome in Acute and Chronic HIV infectionU01HL098996 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 2009 to 2013
$3.9M
Interactions of smoking, PD-1 and IL-10 in HIV-associated lung diseaseU01HL121816 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI CAMPBELL, THOMAS B., FONTENOT, ANDREW P. · 2013 to 2017
$3.4M
Genotypic and functional properties of HIV-1 Nef clinical isolates in PAH-HIVU01HL121819 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BULL, TODD M, FLORES, SONIA CASTRO · 2013 to 2017
$3.3M
Patient-Oriented Research in Immunologic Lung Disease.K24HL102245 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI FONTENOT, ANDREW P. · 2010 to 2020
$1.4M
NCATS NIH HHS UL1 TR000154NCATS NIH HHS UL1 TR001082NHLBI NIH HHS HL102245NHLBI NIH HHS HL121816NHLBI NIH HHS HL98996NHLBI NIH HHS K24 HL102245NHLBI NIH HHS U01 HL098996NHLBI NIH HHS U01 HL121816NHLBI NIH HHS U01 HL121819NIAID NIH HHS T32 AI007405
6 · The paper itself

Abstract

rationaleLymphocytic alveolitis in HIV-1-infected individuals is associated with multiple pulmonary complications and a poor prognosis. Although lymphocytic alveolitis has been associated with viremia and an increased number of CD8(+) T cells in the lung, its exact cause is unknown.

objectivesTo determine if HIV-1-specific T cells are associated with lymphocytic alveolitis in HIV-1-infected individuals.

methodsUsing blood and bronchoalveolar lavage (BAL) cells from normal control subjects and untreated HIV-1-infected individuals, we examined the frequency and functional capacity of HIV-1-specific T cells. MEASUREMENTS AND MAIN

resultsWe found that HIV-1-specific T cells were significantly elevated in the BAL compared with blood of HIV-1-infected individuals and strongly correlated with T-cell alveolitis. Expression of Ki67, a marker of in vivo proliferation, was significantly reduced on HIV-1-specific T cells in BAL compared with blood, suggesting a diminished proliferative capacity. In addition, HIV-1-specific CD4(+) and CD8(+) T cells in BAL had higher expression of programmed death 1 (PD-1) and lower cytotoxic T-lymphocyte antigen 4 (CTLA-4) expression than those in the blood. A strong correlation between PD-1, but not CTLA-4, and HIV-1-specific T-cell proliferation was seen, and blockade of the PD-1/PD-L1 pathway augmented HIV-1-specific T-cell proliferation, suggesting that the PD-1 pathway was the main cause of reduced proliferation in the lung.

conclusionsThese findings suggest that alveolitis associated with HIV-1 infection is caused by the recruitment of HIV-1-specific CD4(+) and CD8(+) T cells to the lung. These antigen-specific T cells display an impaired proliferative capacity that is caused by increased expression of PD-1.

Indexed as

BiomarkersBronchoalveolar Lavage FluidCase-Control StudiesCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesFlow CytometryFluorescent Antibody TechniqueHIV-1HIV AntigensHIV InfectionsHumansLungLung DiseasesLymphocyte ActivationProgrammed Cell Death 1 ReceptorBiomarkersHIV AntigensProgrammed Cell Death 1 ReceptorcytokinesHIVlungprogrammed cell death 1 receptorT cells

Identifiers

PMID25536276
PMCPMC4351596
OpenAlexW2145510581

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.